Written description under 35 U.S.C. §112 is a primary battleground for antibody patent disputes. Small molecule compounds with a small change in structure may possess very different properties, while ...

Few areas of patent law have engendered as much debate and commentary as the written-description requirement. Federal Circuit judges fuel the debate by falling into three groups with divergent views.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

This panel will discuss the current state of the written description requirement, the tension between the statute and Supreme Court interpretation, how the Federal Circuit case law is evolving, what ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Court Will Revisit Ariad Case to Clarify the Amount of Disclosure Necessary in Patents The Federal Circuit recently agreed to rehear Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. en banc to resolve ...

Decision draws more scrutiny to the validity of broad claims and impacts the decision on when to file an application. In an en banc decision issued March 22, the Court of Appeals for the Federal ...

The specification of a United States patent must “contain a written description of the invention, and of the manner and process of making and using it, in such full ...